VAC∆6 vaccine
/ State Research Center of Virology and Biotechnology Vector
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
May 06, 2023
Study on Immunogenicity, Reactogenicity and Safety of the VACΔ6 Vaccine in Volunteers Aged 18-60 Years
(clinicaltrials.gov)
- P2/3 | N=334 | Completed | Sponsor: Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector"
New P2/3 trial • Infectious Disease
1 to 1
Of
1
Go to page
1